相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting RET for thyroid cancer therapy
Cinzia Lanzi et al.
BIOCHEMICAL PHARMACOLOGY (2009)
MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer
Wenqing Qi et al.
BMC CANCER (2009)
Role of Overexpression of CD151 and/or c-Met in Predicting Prognosis of Hepatocellular Carcinoma
Ai-Wu Ke et al.
HEPATOLOGY (2009)
Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities
A. Machens et al.
JOURNAL OF INTERNAL MEDICINE (2009)
The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis
Weon-Kyoo You et al.
BMB REPORTS (2008)
PDGFRA mutations in gastrointestinal stromal tumors: Frequency, spectrum and in vitro sensitivity to imatinib
CL Corless et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients
GB Qiao et al.
BRITISH JOURNAL OF CANCER (2005)
FLT3 and acute myelogenous leukemia: Biology, clinical significance and therapeutic applications
AS Advani
CURRENT PHARMACEUTICAL DESIGN (2005)
Homologous recombination and cell cycle checkpoints:: Rad51 in tumour progression and therapy resistance
W Henning et al.
TOXICOLOGY (2003)
The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer
LT Hansen et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
c-kit expression in pediatric solid tumors - a comparative immunohistochemical study
BE Smithey et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors
ML Lux et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
